Symptomzentrierte Ansicht

Diabetes mellitus

Substanzen, die Diabetes mellitus disproportional melden — sortiert nach ROR.

Schmerzen Medikament unwirksam Off-Label-Anwendung Müdigkeit Atemnot Akute Nierenschädigung

60 von 60 angezeigt

Substanz ↓	ROR [95% CI]	Meldungen	Kategorie	Fachinformation
ziprasidone mesylate —	19.9 [18.7–21.3]	960	algemeen	neu
ziprasidone hydrochloride —	19.9 [18.7–21.2]	1.040	algemeen	neu
ziprasidone hcl —	16.0 [13.5–18.9]	147	algemeen	neu
ziprasidone —	16.7 [15.7–17.7]	1.142	algemeen	neu
xylometazoline hydrochloride —	13.4 [9.0–20.0]	25	algemeen	neu
vasopressin —	8.5 [7.2–10.2]	129	algemeen	neu
valsartan and hydrochlorothiazide —	9.4 [8.7–10.3]	569	algemeen	neu
valsartan —	4.2 [4.0–4.3]	3.562	algemeen	neu
teprotumumab —	12.8 [11.3–14.6]	240	algemeen	neu
sodium ferric gluconate complex —	16.8 [14.0–20.2]	123	algemeen	neu
sodium citrate —	24.0 [19.8–29.0]	113	algemeen	neu
sitagliptin phosphate —	6.1 [4.7–8.0]	58	algemeen	neu
saxagliptin —	9.1 [6.8–12.2]	47	algemeen	neu
risperidone —	6.2 [5.9–6.4]	2.830	algemeen	neu
ranolazine —	7.1 [6.3–8.0]	259	algemeen	neu
quetiapine —	14.0 [13.7–14.3]	8.348	algemeen	neu
pioglitazone —	4.2 [3.9–4.5]	684	algemeen	neu
phytonadione —	6.1 [5.2–7.0]	180	algemeen	neu
pegvisomant —	10.2 [8.6–12.0]	147	algemeen	neu
oseltamivir acid —	18.4 [15.0–22.5]	101	algemeen	neu
olanzapine pamoate —	39.5 [38.3–40.7]	4.875	algemeen	neu
olanzapine —	15.4 [15.0–15.9]	5.408	algemeen	neu
nateglinide —	5.4 [3.7–8.0]	26	algemeen	neu
metformin hydrochloride —	4.0 [3.8–4.2]	1.271	algemeen	neu
metformin hcl —	4.8 [4.5–5.2]	958	algemeen	neu
metformin er 750 mg —	4.1 [3.9–4.2]	4.169	algemeen	neu
metformin er 500 mg —	4.1 [3.9–4.2]	4.169	algemeen	neu
metformin —	4.2 [4.1–4.3]	6.234	algemeen	neu
medicinal massage oil —	252.5 [190.6–334.4]	94	algemeen	neu
mannitol —	6.8 [5.7–8.2]	118	algemeen	neu
lithium carbonate —	7.6 [6.9–8.3]	467	algemeen	neu
lithium —	5.5 [5.1–5.9]	825	algemeen	neu
lanthanum carbonate —	8.1 [6.8–9.5]	145	algemeen	neu
insulin degludec —	3.8 [3.4–4.3]	334	algemeen	neu
insulin aspart injection —	6.6 [5.1–8.5]	59	algemeen	neu
inclisiran —	3.5 [2.8–4.3]	95	algemeen	neu
human insulin —	5.3 [4.7–6.1]	238	algemeen	neu
glyburide —	5.8 [5.3–6.3]	504	algemeen	neu
glipizide —	5.1 [4.8–5.5]	1.105	algemeen	neu
glimepiride —	3.7 [3.4–4.1]	520	algemeen	neu
gemfibrozil —	6.3 [5.7–7.1]	342	algemeen	neu
famotitine —	6.2 [4.9–8.0]	66	algemeen	neu
ertugliflozin —	3.7 [2.3–6.0]	17	algemeen	neu
dobutamine hydrochloride —	15.7 [12.3–20.1]	68	algemeen	neu
dobutamine —	9.3 [8.0–10.9]	160	algemeen	neu
divalproex sodium —	8.1 [7.7–8.5]	1.307	algemeen	neu
deutetrabenazine —	3.3 [2.7–4.1]	82	algemeen	neu
candesartan cilexetil and hydrochlorothiazide —	8.5 [6.8–10.7]	79	algemeen	neu
calcium carbonate, magnesium hydroxide —	4.2 [3.3–5.3]	74	algemeen	neu
bismuth subsalicylate —	5.8 [4.8–7.0]	119	algemeen	neu
benztropine mesylate —	13.0 [10.8–15.6]	120	algemeen	neu
benztropine —	6.9 [5.9–8.0]	177	algemeen	neu
basiliximab —	4.3 [3.7–5.0]	178	algemeen	neu
aripiprazole —	5.1 [4.9–5.3]	2.221	algemeen	neu
amlodipine valsartan and hydrochlorothiazide —	14.8 [12.8–17.1]	187	algemeen	neu
amlodipine besylate and valsartan —	9.1 [8.1–10.1]	352	algemeen	neu
amlodipine and atorvastatin —	4.7 [3.7–6.0]	69	algemeen	neu
alpelisib —	8.0 [7.0–9.1]	244	algemeen	neu
alogliptin —	4.2 [3.2–5.4]	57	algemeen	neu
allantoin —	9.7 [8.1–11.8]	113	algemeen	neu

ROR = Reporting Odds Ratio gegenüber dem gesamten FAERS-Korpus. Ein Signal ist keine Ursache. Quelle: openFDA (FAERS).